Johns Hopkins ABX Guide
Daclatasvir
Daclatasvir is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of chronic hepatitis C virus (HCV) genotype 1 or 3 infection, in combination with sofosbuvir (SOF).
- Daclatasvir is indicated for treating HIV/HCV co-infected patients in patients with compensated Child-Pugh Class A cirrhosis, decompensated Child-Pugh B or C cirrhosis, and in patients that develop recurrent HCV post-transplant.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Treatment of HCV genotypes 2, 4.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Treatment of chronic hepatitis C virus (HCV) genotype 1 or 3 infection, in combination with sofosbuvir (SOF).
- Daclatasvir is indicated for treating HIV/HCV co-infected patients in patients with compensated Child-Pugh Class A cirrhosis, decompensated Child-Pugh B or C cirrhosis, and in patients that develop recurrent HCV post-transplant.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Treatment of HCV genotypes 2, 4.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 18, 2022
Citation
Auwaerter, Paul G, and Janessa M Smith. "Daclatasvir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540654/12/Daclatasvir.
Auwaerter PG, Smith JM. Daclatasvir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540654/12/Daclatasvir. Accessed January 27, 2023.
Auwaerter, P. G., & Smith, J. M. (2022). Daclatasvir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540654/12/Daclatasvir
Auwaerter PG, Smith JM. Daclatasvir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2023 January 27]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540654/12/Daclatasvir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Daclatasvir
ID - 540654
A1 - Auwaerter,Paul,M.D.
AU - Smith,Janessa,PharmD, BCPS
Y1 - 2022/10/18/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540654/12/Daclatasvir
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
